ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 148 filers reported holding ANAVEX LIFE SCIENCES CORP in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,682 | -20.9% | 12,929 | -1.6% | 0.00% | – |
| Q2 2023 | $107,002 | -15.4% | 13,142 | -11.2% | 0.00% | – |
| Q1 2023 | $126,522 | -18.1% | 14,794 | -11.1% | 0.00% | – |
| Q4 2022 | $154,486 | +56.0% | 16,638 | +73.8% | 0.00% | – |
| Q3 2022 | $99,000 | -13.2% | 9,573 | -15.9% | 0.00% | – |
| Q2 2022 | $114,000 | -61.2% | 11,386 | -33.1% | 0.00% | -100.0% |
| Q1 2022 | $294,000 | -10.9% | 17,031 | -10.8% | 0.00% | 0.0% |
| Q4 2021 | $330,000 | -66.4% | 19,087 | -65.1% | 0.00% | -50.0% |
| Q3 2021 | $981,000 | +35.9% | 54,696 | +70.9% | 0.00% | 0.0% |
| Q2 2021 | $722,000 | +375.0% | 32,002 | +215.4% | 0.00% | – |
| Q1 2021 | $152,000 | +334.3% | 10,145 | +58.8% | 0.00% | – |
| Q4 2020 | $35,000 | -23.9% | 6,387 | -37.6% | 0.00% | – |
| Q3 2020 | $46,000 | -28.1% | 10,237 | -21.2% | 0.00% | – |
| Q2 2020 | $64,000 | +52.4% | 12,987 | -3.3% | 0.00% | – |
| Q1 2020 | $42,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 942,500 | $9,727,000 | 3.29% |
| Pier Capital, LLC | 384,811 | $3,971,000 | 0.68% |
| AllSquare Wealth Management LLC | 65,956 | $681,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $1,032,000 | 0.35% |
| Royal Capital Wealth Management, LLC | 18,500 | $191,000 | 0.22% |
| Bridgefront Capital, LLC | 10,214 | $105,000 | 0.11% |
| Hikari Power Ltd | 85,585 | $883,000 | 0.10% |
| Orion Capital Management LLC | 9,500 | $98,000 | 0.08% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,158 | $889,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 66,459 | $686,000 | 0.04% |